Amgen Inc.(AMGN)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
AMGN | 240.11 B | 27.60x | 9.50% | 22.95% | $16.09 | 91.47% | 4.90 | 2.33% | $447.03 | $262.49 |
LLY | 1.03 T | 39.47x | 47.70% | 33.53% | $29.38 | 1.02% | 1.62 | 59.00% | $1292.65 | $707.59 |
JNJ | 670.99 B | 32.53x | 6.60% | 21.48% | $8.56 | 25.74% | 0.58 | 2.00% | $275.11 | $169.51 |
ABBV | 459.82 B | 73.09x | 10.20% | 9.80% | $3.56 | - | - | 2.71% | $267.47 | $189.40 |
AZN | 255.54 B | 24.63x | 6.40% | 17.02% | $6.69 | 21.97% | 0.64 | 1.96% | $210.52 | $144.30 |
NVO | 158.93 B | 11.62x | 2.10% | 35.35% | $4.09 | 59.82% | 0.63 | 3.96% | $61.11 | $34.15 |
Peer Valuation & Performance Analysis
Peer group analysis for Amgen Inc. (AMGN) compared to its primary competitors (including LLY, JNJ, ABBV) reveals distinct metrics. AMGN trades at a valuation discount relative to its competitors, with a P/E ratio of 27.6x versus the peer average of 36.9x (representing a 25% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, AMGN's revenue growth of 9.5% lags behind the peer average of 12.7%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 22.9% compared to the peer average of 20.9%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• AMGN ranks #2 in P/E ratio, #3 in revenue growth, and #2 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $445.67 | $445.82 | $438.08 | $444.12 | 1,842,300 | -0.35% |
| 2026-09-02 | $440.65 | $445.57 | $435.00 | $442.84 | 2,285,500 | +0.50% |
| 2026-09-01 | $435.30 | $438.65 | $431.00 | $438.12 | 2,358,200 | +0.65% |
| 2026-08-31 | $428.59 | $431.85 | $426.00 | $429.88 | 2,339,500 | +0.30% |
| 2026-08-28 | $437.89 | $437.89 | $430.72 | $432.42 | 1,739,700 | -1.25% |
| 2026-08-27 | $433.08 | $442.13 | $431.01 | $436.99 | 1,761,500 | +0.90% |
| 2026-08-26 | $441.00 | $442.89 | $438.24 | $440.34 | 2,289,000 | -0.15% |
| 2026-08-25 | $443.26 | $447.03 | $441.26 | $442.24 | 2,100,900 | -0.23% |
| 2026-08-24 | $440.31 | $445.87 | $435.51 | $443.84 | 2,463,300 | +0.80% |
| 2026-08-21 | $431.72 | $440.51 | $429.38 | $439.33 | 2,114,300 | +1.76% |
| 2026-08-20 | $433.25 | $438.78 | $428.57 | $431.21 | 2,914,300 | -0.47% |
| 2026-08-19 | $430.24 | $443.20 | $429.38 | $442.36 | 2,543,400 | +2.82% |
| 2026-08-18 | $421.64 | $427.39 | $420.72 | $425.28 | 2,591,400 | +0.86% |
| 2026-08-17 | $412.98 | $419.60 | $410.40 | $419.38 | 2,880,500 | +1.55% |
| 2026-08-14 | $413.76 | $416.03 | $410.50 | $415.21 | 2,036,200 | +0.35% |
Explore More Analysis for AMGN
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.